Institute for Integration of Medicine & Science

At a Glance


Educational Resources Posted


Consortium News Stories Posted


Events Posted


Opportunities Posted


Publications citing CTSA Program Grant


Users from Hub Registered

UL1 Award

KL2 Award

TL1 Award

Funded Years
2013 - 2021
Connect with Us


The Center for Research to Advance Community Health (ReACH) under the Joe R. and Teresa Lozano Long School of Medicine at UT Health San Antonio invites applications for faculty positions at the Assistant Professor/Associate Professor/Professor level. Two positions are available. The ReACH Center, directed by Joel Tsevat, MD, MPH, offers a unique environment for inter-disciplinary, collaborative

Poster Sessions

CIDD in San Antonio – an Integrated Model for Early Stage Drug Discovery in Academia
University Of Texas Health Science Center

The Center for Innovative Drug Discovery (CIDD), a joint-venture between the University of Texas Health at San Antonio (UTHealthSA) and the University of Texas at San Antonio (UTSA), provides core-based services that support biomedical research related to drug discovery. The primary goal of CIDD is to provide a diverse array of technologies and expertise to enable the translation of basic


Racial and gender differences in the relationship between sarcopenia and bone mineral density among older adults

Both sarcopenia and low bone mineral density (BMD) have become public health concerns. We found that presarcopenic and/or sarcopenic individuals were more likely to have lower BMD. And this relationship has race and sex-specific discrepancy. The purpose of the study was to investigate the racial and

Assessing acceptability and patient experience of a behavioral lifestyle intervention using fitbit technology in older adults to manage type 2 diabetes amid COVID-19 pandemic: A focus group study

Type 2 diabetes (T2D) contributes to reduced quality of life in older adults, especially in those with comorbidities such as being overweight or obese. Personal fitness technology (Fitbit ®) has the potential to improve the management of T2D. Using a semi-structured interview guide, focus groups

Using the Schmahmann Syndrome Scale to Assess Cognitive Impairment in Young Adults with Metabolic Syndrome: a Hypothesis-Generating Report

The posterior cerebellum is the most significantly compromised brain structure in individuals with metabolic syndrome (MetS) (Hum Brain Mapp 40(12):3575-3588, 2019). In light of this, we hypothesized that cognitive decline reported in patients with MetS is likely related to posterior cerebellar